[8-K] Dolby Laboratories, Inc. Reports Material Event

Rhea-AI Filing Summary

Dolby Laboratories, Inc. reported that it has released its financial results for the fiscal quarter and fiscal year ended September 26, 2025, via a press release that is incorporated by reference as Exhibit 99.1. The company also declared a cash dividend of $0.36 per share on its Class A and Class B common stock, payable on December 10, 2025, to stockholders of record as of the close of business on December 2, 2025. Dolby noted that it regularly shares information with the public through its main website, investor relations site, SEC filings, press releases, conference calls, and webcasts.

Insights

Equity income & dividends analyst

Dolby declared a regular cash dividend and released annual and quarterly results.

Dolby Laboratories announced that it has issued its financial results for the fiscal quarter and fiscal year ended September 26, 2025, through a press release furnished as Exhibit 99.1. This indicates completion of its reporting cycle for that fiscal year but does not itself reveal revenue or earnings figures in this excerpt.

The company also declared a cash dividend of $0.36 per share on both Class A and Class B common stock, with a record date of December 2, 2025 and payment on December 10, 2025. This reflects an ongoing capital return policy but the excerpt does not compare it to prior dividends, so its growth or change cannot be evaluated here.

Dolby highlighted that it provides material information through multiple channels, including its websites, SEC filings, press releases, and public calls. For investors, the detailed financial performance and any commentary would be found in the referenced press release for the period ended September 26, 2025.

false 0001308547 0001308547 2025-11-18 2025-11-18

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

November 18, 2025

DOLBY LABORATORIES, INC.

(Exact name of registrant as specified in its charter)

Delaware		001-32431		90-0199783
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

1275 Market Street

San Francisco, CA 94103-1410

(Address of principal executive offices) (Zip Code)

(415) 558-0200

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Class A common stock, $0.001 par value		DLB		The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition.

The following information is intended to be furnished under Item 2.02 of Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

On November 18, 2025, Dolby Laboratories, Inc. (the “Company”) issued a press release announcing its financial results for its fiscal quarter and fiscal year ended September 26, 2025. The full text of the press release is furnished as Exhibit 99.1 and is incorporated herein by reference.

Item 8.01 Other Events

Declaration of Dividend

On November 18, 2025, the Company announced a cash dividend of $0.36 per share of Class A and Class B Common Stock, payable on December 10, 2025 to stockholders of record as of the close of business on December 2, 2025.

Disclosure Channels to Disseminate Information

The Company disseminates information to the public about the Company, its products, services and other matters through various channels, including the Company’s website (www.dolby.com), investor relations website (http://investor.dolby.com), SEC filings, press releases, public conference calls and webcasts, in order to achieve broad, non-exclusionary distribution of information to the public. The Company encourages investors and others to review the information it makes public through these channels, as such information could be deemed to be material information.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
99.1		Press Release of Dolby Laboratories, Inc. dated November 18, 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		DOLBY LABORATORIES, INC.
By:		/s/ Robert Park
		Robert Park Senior Vice President and Chief Financial Officer (Principal Financial Officer)

Date: November 18, 2025

FAQ

What did Dolby Laboratories (DLB) announce in this Form 8-K?

Dolby Laboratories announced that it released its financial results for the fiscal quarter and fiscal year ended September 26, 2025, via a press release furnished as Exhibit 99.1, and it declared a cash dividend on its common stock.

What dividend did Dolby Laboratories (DLB) declare and on which shares?

Dolby Laboratories declared a cash dividend of $0.36 per share on its Class A and Class B common stock.

When will Dolby Laboratories (DLB) pay the declared dividend and what is the record date?

The $0.36 per share dividend will be payable on December 10, 2025 to stockholders of record as of the close of business on December 2, 2025.

Where can investors find Dolby Laboratories' detailed financial results for the year ended September 26, 2025?

Investors can find the detailed financial results in the press release dated November 18, 2025, which is furnished as Exhibit 99.1 and incorporated by reference.

Through which channels does Dolby Laboratories (DLB) disseminate important company information?

Dolby disseminates information through its main website (www.dolby.com), its investor relations website (http://investor.dolby.com), SEC filings, press releases, and public conference calls and webcasts.

Does this 8-K state whether the furnished financial information is considered filed with the SEC?

The company states that the information furnished under Item 2.02, including the press release, is not deemed "filed" for purposes of Section 18 of the Exchange Act or incorporated by reference into other filings, except where specifically referenced.